🎥 Discover how the partners of the IMPACT project are contributing to a deeper understanding of cardiovascular disease mechanisms and to the development of innovative tools and therapeutic strategies.
💡 Alessandra Rampazzo – Principal Investigator of the project – and Milena Bellin from the University of Padova present the project’s objectives and methodology, highlighting recent progress toward novel therapeutic approaches.
💡 Michele Crudele from Lutech explains how AI-driven models are enhancing the analysis of immunofluorescence, histological and electron microscopy images, transforming complex biomedical data into actionable insights.
💡 Christian Steinkuhler of Italfarmaco outlines the company’s dual involvement in IMPACT: providing highly characterized tool compounds for partner analyses and exploring biological links between Duchenne muscular dystrophy and ACM to inform new research directions.
💡 Magdalena Harakalova from UMC Utrecht describes how integrated patient datasets – including tissue, genetic, and imaging data – allow her team to map disease progression, identify new biomarkers and improve patient stratification.
💡 Finally, Mariana Branco of CoLAB AccelBio presents advanced cardiac organoid models derived from hiPSCs, which replicate both the structural and functional features of the human ventricular myocardium and offer powerful systems to investigate disease mechanisms.
Together, these interviews showcase the interdisciplinary strength of IMPACT and the valuable expertise of its partners, demonstrating how collaborative innovation is driving the project toward meaningful advancements in cardiovascular research.
⬇️ You can see all the complete video-interviews below:
| Alessandra Rampazzo & Milena Bellin | |
| Michele Crudele | Christian Steinkuhler |
| Magdalena Harakalova | Mariana Branco |
